News About: Goverment
Pharma Science Korea is entering into domestic market in earnest
Pharma Science Korea which is a joint company of Kolmar Korea and Canadian generic specialized company Science, is entering into domestic market in earnest.
On June 3, according to the related industry, Pharma Scienc...
It was analyzed that trade deficit range of medicine is gradually getting bigger after the Korea-US FTA
It was analyzed that trade deficit range of medicine is gradually getting bigger after the Korea-US FTA.
On June 2, Health Industry Development Institute published brief 'Import and export trade effect on Health Indu...
Government completed reimbursement negotiation of 2015
Government completed reimbursement negotiation of 2015. The chief beneficiary of reimbursement negotiation is KPA, which recorded rise rate of 3.2%, which is 0.4% higher than the rise rate in 2014.
KMA signed a contr...
Partial insurance benefit restriction of Stillen was suspended until June 20
Partial insurance benefit restriction of Stillen was suspended until June 20. Thus, patients can receive insurance benefit of Stillen when used for the purpose of preventing gastritis which is caused by NSAIDs.
Seoul...
Pfizer Korea appealed administrative judgment, for the purpose of returning the price of neuropathic pain treatment ‘Lyrica’ to the original state
Pfizer Korea appealed administrative judgment to Anti-Corruption and Civil Rights Commission for the purpose of returning the price of neuropathic pain treatment ‘Lyrica’ (pregabalin) to the original state.
Pfizer Ko...
Multinational pharmaceutical companies are expressing disapproval on the report of Phase 4 clinical trial adverse reactions
Multinational pharmaceutical companies are expressing disapproval on the report of Phase 4 clinical trial adverse reactions. They insist that it is difficult to follow the same rules of Ministry of Food and Drug Safet...
There came out the final ruling that it is reasonable to refuse the registration of a patent of Telmisartan for the purpose of diabetes treatment
There came out the final ruling that it is reasonable to refuse the registration of a patent of Telmisartan for the purpose of diabetes treatment.
Behringer applied for a patent in January 2006, but the Korean Intell...
The number of patients who receive health care treatment for 'Chronic obstructive pulmonary disease (J44, COPD)' is increasing year after year
The number of patients who receive health care treatment for 'Chronic obstructive pulmonary disease (J44, COPD)' is increasing year after year. The number of male patients are 1.8 times than that of female patients, r...
It was analyzed that the amount of insurance benefit is higher than insurance fee
According to the result of '2013 status analysis on the rate of insurance benefit to insurance fee' released by National Health Insurance Corporation, the entire monthly premium per household was 92,506 won and insura...
The number of doctor per 100,000 population increased by 390%
According to the '2013 analysis report on current status of national member' which is released by Korean Medical Association, Institute for Health Policy, the number of doctors on 1980 was 22,564. The number of doctor...
